Sign Up for a StudyClick Here

Monday–Thursday: 8:30AM–6:00PM PST

Contact Us

Active Clinical Trials and Studies

Excell Research may be seeking participants for an upcoming clinical research study for an area or disease that is relevant to you or someone you know.

Clinical Research Trials

Clinical research trials and those who contribute play a role in the development of new treatments for some of our most common and debilitating diseases and conditions.

Patients who participate in Excell’s clinical research trials have an opportunity to join the vanguard of scientific research and contribute to the progress, knowledge, and future treatment of medical conditions.

We will provide you with comprehensive information and straightforward answers to your questions regarding the risks and benefits of participating.

Financial compensation may be available to those who qualify and complete visits for clinical trials at Excell.

Sign up for a trial today!

Depression Clinical Research Trials

Major Depressive Disorder Clinical Trial A

Summary: The purpose of this study is to determine efficacy differences between the investigational medication and placebo, used either as monotherapy or adjunctively to an antidepressant, related to patient characteristics.

Eligibility Criteria

Key Inclusion Criteria:

  • Symptoms of depression for at least 6 weeks prior to entering the study.
  • Willing to comply with all study assessments and procedures.
  • Willing to either not take an antidepressant medication, or continue taking a single SSRI, SNRI, mirtazapine, or bupropion with no dose changes 2 weeks prior to medication or placebo distribution.

Key Exclusion Criteria:

  • Diagnosed with bi-polar disorder, schizophrenia, psychotic disorders, or dementia.
  • Primary symptoms of post-traumatic stress disorder.
  • Clinically significant medical conditions.
  • History of substance abuse in the past 3 months.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18-70

Sign-Up
Generalized Anxiety Clinical Research Trials

Generalized Anxiety Disorder (GAD) Study A

Summary: A clinical study that will measure how well the investigational medication works and how safe it is in adults with Generalized Anxiety Disorder. This study will be accepting both male and female subjects between the ages of 18 years and 65 years old. The investigational medication is in the form of a tablet taken daily. The study may last up to 12 weeks long.

Eligibility Criteria:

Key Inclusion Criteria:

  • Male or female subject between 18 to 65 years of age.
  • Symptoms of Generalized Anxiety Disorder over the past 6 months.
  • Primary focus of treatment is Generalized Anxiety Disorder.

Key Exclusion Criteria:

  • Diagnosis other than Generalized Anxiety Disorder that was the primary focus of treatment within 12 months before Screening.
  • Previous inadequate response to more than 3 antidepressant treatments.
  • Any clinically significant unstable medical condition or any clinically significant chronic disease, that would limit the subject’s ability to complete and/or participate in the study.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18 to 65

Sign-Up
Schizophrenia Clinical Research Trials

Schizophrenia Study A

Summary: Study to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia. The investigational medication is an oral tablet.

Eligibility Criteria

Key Inclusion Criteria:

  • Experiencing cognitive impairment with a previous diagnosis of Schizophrenia.
  • Willing to comply with all study assessments and procedures.
  • Currently taking an antipsychotic medication for at least 3 weeks prior to study entry at a 2-6mg Risperidone equivalent.

Key Exclusion Criteria:

  • Diagnosed with bi-polar disorder or other non-schizophrenic psychotic disorders.
  • Current substance/alcohol abuse.
  • Clinically significant medical conditions.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18-50

Sign-Up
OCD Clinical Research Trials

Obsessive Compulsive Disorder (OCD) Study A

Summary: The study’s purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compulsive Disorder (OCD). The investigational medication is in the form of a oral pill.

Eligibility Criteria:

Key Inclusion Criteria:

  • Experiencing moderate to severe symptoms of obsessive-compulsive disorder in the past year.
  • Currently taking an SSRI medication for 8 weeks prior to study entry. (Zoloft, Prozac, Lexapro, Celexa, ect.)
  • Willing to stop exclusionary psychiatric medications prior to study entry.

Key Exclusion Criteria:

  • Lifetime history of bi-polar disorder, schizophrenia, borderline personality disorder or autism spectrum disorders.
  • Unwilling to discontinue exclusionary medications or comply with study procedures.
  • Any clinically significant unstable medical condition or any clinically significant chronic disease.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18 to 65

Sign-Up
Adolescent Migraine Clinical Research Trials

Adolescent Migraine Study A

Summary: Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how safe and effective ubrogepant is in the acute treatment of migraine in children and adolescents.

Ubrogepant is a drug approved for the acute treatment of migraine in adults. Adolescents (aged 12-17 years) with a history of migraine will be enrolled. Adolescents aged 12-17 years will be randomized to receive either low or high dose of Ubrogepant or placebo with a 1 in 3 chance of placebo assignment.

Eligibility Criteria

Key Inclusion Criteria:

  • History of 1 to 14 migraine attacks per month with moderate to severe headaches in each of the 2 months prior to study entry.
  • Current or past use of at least 1 oral medication (over-the-counter medication or prescription medication) for the acute treatment of migraine.

Key Exclusion Criteria:

  • Any clinically significant hematologic, endocrine, pulmonary, renal, hepatic, gastrointestinal, cardiovascular, or neurologic disease.
  • Other confounding pain syndromes, confounding psychiatric conditions, or other significant neurological disorders other than migraine.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

12-17

Sign-Up
Excell Research Clinical Research StudiesQuick Sign Up Form

Please enable JavaScript in your browser to complete this form.
Name
Please provide your legal name.

Please provide the best number to reach you, including the area code.

Please provide the best email to reach you.
Birth Date
Please provide your date of birth.

Please provide your zip code for location verification
Do you currently have, or have you ever had, any of the following?
Are you willing to take an investigational medication as a part of the trial?
Best Time and Date for us to reach you

Please let us know your preferred date and time for the call.
Expect a call from Excell Research Monday through Thursday between 8:30am and 6:00pm PT at 760-758-2222

Clinical Trial Studies

Excell Research Clinical Research StudiesWhy Participate?

For those interested in participating in clinical research trials, Excell has a variety of studies that are testing new or investigational medications at no cost to clinical research study participants! Learn more about how new treatments may help with your symptoms.

Sign up to learn more

Learn More About Clinical Research Trials

Participants

What are Clinical Research Trials?

Clinical research trials offer patients new opportunities for diverse treatments and personalized care from healthcare professionals. These trials often provide financially feasible treatment options, contributing to medical progress and advancing patient care.

New Treatments For Longer and Better-Quality Lives

The primary aim of clinical research trials is to establish the effectiveness and safety of new treatments, potentially offering cures or improved management for chronic conditions. Participating in these trials allows access to cutting-edge treatments while contributing to longer, higher-quality lives for others.

Patient Safety

To ensure the safety of patients during clinical research trials, Excell follows guidelines set by organizations such as the U.S. Food & Drug Administration and the Global International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practices (ICH GCP).

According to requirements of the Medical Board of California, medical providers at Excell Research are providing information about the Open Payments Database.  The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.  This database was created so that patients can be informed of any possible influence pharmaceutical companies may have on their physician.  As a dedicated research facility, the entirety of Excell Research’s income is from pharmaceutical companies; however, medical providers are paid for their work by Excell Research and not directly by any pharmaceutical company.

Learn more about the company on the About Us page.

Get updates on Clinical Trials and Studies at Excell ResearchSign up for monthly updates for Clinical Trials and Studies at Excell Research

In partnership with Researchify Health, refer someone you known or sign up to receive digital communications about current and upcoming studies at Excell.
Monthly Study Updates
https://excellresearch.com/wp-content/uploads/2023/08/qtq80-lHlUrD.jpeg

Active Clinical Trials and Studies

Excell Research may be seeking participants for an upcoming clinical research study for an area or disease that is relevant to you or someone you know.

Clinical Research Trials

Clinical research trials and those who contribute play a role in the development of new treatments for some of our most common and debilitating diseases and conditions.

Patients who participate in Excell’s clinical research trials have an opportunity to join the vanguard of scientific research and contribute to the progress, knowledge, and future treatment of medical conditions.

We will provide you with comprehensive information and straightforward answers to your questions regarding the risks and benefits of participating.

Financial compensation may be available to those who qualify and complete visits for clinical trials at Excell.

Sign up for a trial today!

Depression Clinical Research Trials

Major Depressive Disorder Clinical Trial A

Summary: The purpose of this study is to determine efficacy differences between the investigational medication and placebo, used either as monotherapy or adjunctively to an antidepressant, related to patient characteristics.

Eligibility Criteria

Key Inclusion Criteria:

  • Symptoms of depression for at least 6 weeks prior to entering the study.
  • Willing to comply with all study assessments and procedures.
  • Willing to either not take an antidepressant medication, or continue taking a single SSRI, SNRI, mirtazapine, or bupropion with no dose changes 2 weeks prior to medication or placebo distribution.

Key Exclusion Criteria:

  • Diagnosed with bi-polar disorder, schizophrenia, psychotic disorders, or dementia.
  • Primary symptoms of post-traumatic stress disorder.
  • Clinically significant medical conditions.
  • History of substance abuse in the past 3 months.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18-70

Sign-Up
Generalized Anxiety Clinical Research Trials

Generalized Anxiety Disorder (GAD) Study A

Summary: A clinical study that will measure how well the investigational medication works and how safe it is in adults with Generalized Anxiety Disorder. This study will be accepting both male and female subjects between the ages of 18 years and 65 years old. The investigational medication is in the form of a tablet taken daily. The study may last up to 12 weeks long.

Eligibility Criteria:

Key Inclusion Criteria:

  • Male or female subject between 18 to 65 years of age.
  • Symptoms of Generalized Anxiety Disorder over the past 6 months.
  • Primary focus of treatment is Generalized Anxiety Disorder.

Key Exclusion Criteria:

  • Diagnosis other than Generalized Anxiety Disorder that was the primary focus of treatment within 12 months before Screening.
  • Previous inadequate response to more than 3 antidepressant treatments.
  • Any clinically significant unstable medical condition or any clinically significant chronic disease, that would limit the subject’s ability to complete and/or participate in the study.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18 to 65

Sign-Up
Schizophrenia Clinical Research Trials

Schizophrenia Study A

Summary: Study to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia. The investigational medication is an oral tablet.

Eligibility Criteria

Key Inclusion Criteria:

  • Experiencing cognitive impairment with a previous diagnosis of Schizophrenia.
  • Willing to comply with all study assessments and procedures.
  • Currently taking an antipsychotic medication for at least 3 weeks prior to study entry at a 2-6mg Risperidone equivalent.

Key Exclusion Criteria:

  • Diagnosed with bi-polar disorder or other non-schizophrenic psychotic disorders.
  • Current substance/alcohol abuse.
  • Clinically significant medical conditions.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18-50

Sign-Up
OCD Clinical Research Trials

Obsessive Compulsive Disorder (OCD) Study A

Summary: The study’s purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compulsive Disorder (OCD). The investigational medication is in the form of a oral pill.

Eligibility Criteria:

Key Inclusion Criteria:

  • Experiencing moderate to severe symptoms of obsessive-compulsive disorder in the past year.
  • Currently taking an SSRI medication for 8 weeks prior to study entry. (Zoloft, Prozac, Lexapro, Celexa, ect.)
  • Willing to stop exclusionary psychiatric medications prior to study entry.

Key Exclusion Criteria:

  • Lifetime history of bi-polar disorder, schizophrenia, borderline personality disorder or autism spectrum disorders.
  • Unwilling to discontinue exclusionary medications or comply with study procedures.
  • Any clinically significant unstable medical condition or any clinically significant chronic disease.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18 to 65

Sign-Up
Adolescent Migraine Clinical Research Trials

Adolescent Migraine Study A

Summary: Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how safe and effective ubrogepant is in the acute treatment of migraine in children and adolescents.

Ubrogepant is a drug approved for the acute treatment of migraine in adults. Adolescents (aged 12-17 years) with a history of migraine will be enrolled. Adolescents aged 12-17 years will be randomized to receive either low or high dose of Ubrogepant or placebo with a 1 in 3 chance of placebo assignment.

Eligibility Criteria

Key Inclusion Criteria:

  • History of 1 to 14 migraine attacks per month with moderate to severe headaches in each of the 2 months prior to study entry.
  • Current or past use of at least 1 oral medication (over-the-counter medication or prescription medication) for the acute treatment of migraine.

Key Exclusion Criteria:

  • Any clinically significant hematologic, endocrine, pulmonary, renal, hepatic, gastrointestinal, cardiovascular, or neurologic disease.
  • Other confounding pain syndromes, confounding psychiatric conditions, or other significant neurological disorders other than migraine.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

12-17

Sign-Up
Excell Research Clinical Research StudiesQuick Sign Up Form

Please enable JavaScript in your browser to complete this form.
Name
Please provide your legal name.

Please provide the best number to reach you, including the area code.

Please provide the best email to reach you.
Birth Date
Please provide your date of birth.

Please provide your zip code for location verification
Do you currently have, or have you ever had, any of the following?
Are you willing to take an investigational medication as a part of the trial?
Best Time and Date for us to reach you

Please let us know your preferred date and time for the call.
Expect a call from Excell Research Monday through Thursday between 8:30am and 6:00pm PT at 760-758-2222

Clinical Trial Studies

Excell Research Clinical Research StudiesWhy Participate?

For those interested in participating in clinical research trials, Excell has a variety of studies that are testing new or investigational medications at no cost to clinical research study participants! Learn more about how new treatments may help with your symptoms.

Sign up to learn more

Learn More About Clinical Research Trials

Participants

What are Clinical Research Trials?

Clinical research trials offer patients new opportunities for diverse treatments and personalized care from healthcare professionals. These trials often provide financially feasible treatment options, contributing to medical progress and advancing patient care.

New Treatments For Longer and Better-Quality Lives

The primary aim of clinical research trials is to establish the effectiveness and safety of new treatments, potentially offering cures or improved management for chronic conditions. Participating in these trials allows access to cutting-edge treatments while contributing to longer, higher-quality lives for others.

Patient Safety

To ensure the safety of patients during clinical research trials, Excell follows guidelines set by organizations such as the U.S. Food & Drug Administration and the Global International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practices (ICH GCP).

According to requirements of the Medical Board of California, medical providers at Excell Research are providing information about the Open Payments Database.  The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.  This database was created so that patients can be informed of any possible influence pharmaceutical companies may have on their physician.  As a dedicated research facility, the entirety of Excell Research’s income is from pharmaceutical companies; however, medical providers are paid for their work by Excell Research and not directly by any pharmaceutical company.

Learn more about the company on the About Us page.

Get updates on Clinical Trials and Studies at Excell ResearchSign up for monthly updates for Clinical Trials and Studies at Excell Research

In partnership with Researchify Health, refer someone you known or sign up to receive digital communications about current and upcoming studies at Excell.
Monthly Study Updates
https://excellresearch.com/wp-content/uploads/2023/08/qtq80-lHlUrD.jpeg